BATON ROUGE, La., Feb. 28, 2017 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ:AMED) today reported its financial results for the three month period and year ended December 31, 2016.
Three Month Periods Ended December 31, 2016 and 2015
- Net service revenue increased $27.9 million to $366.3 million compared to $338.4 million in 2015.
- Net income attributable to Amedisys, Inc. of $8.9 million compared to $12.9 million in 2015.
- Net income attributable to Amedisys, Inc. per diluted share of $0.26 per diluted share compared to $0.38 in 2015.
Adjusted Quarterly Results*
- Adjusted net service revenue increased $27.8 million to $365.1 million compared to $337.3 million in 2015.
- Adjusted EBITDA of $30.5 million compared to $27.6 million in 2015.
- Adjusted net income attributable to Amedisys, Inc. of $15.0 million compared to $13.4 million in 2015.
- Adjusted net income attributable to Amedisys, Inc. per diluted share of $0.44 compared to $0.40 in 2015.
Years Ended December 31, 2016 and 2015
- Net service revenue increased $156.9 million to $1,437.4 million compared to $1,280.5 million in 2015.
- Net income attributable to Amedisys, Inc. of $37.3 million compared to $3.0 million net loss in 2015.
- Net income attributable to Amedisys, Inc. per diluted share of $1.10 compared to $0.09 net loss per diluted share in 2015.
Adjusted Year End Results*
- Adjusted net service revenue increased $157.8 million to $1,437.3 million compared to $1,279.5 million in 2015.
- Adjusted EBITDA of $109.9 million compared to $112.0 million in 2015.
- Adjusted net income attributable to Amedisys, Inc. of $52.2 million compared to $48.9 million in 2015.
- Adjusted net income attributable to Amedisys, Inc. per diluted share of $1.55 compared to $1.48 in 2015.
* See Reconciliation of Non-GAAP Financial Measures to GAAP Measures in the table below.
Paul B. Kusserow, President and Chief Executive Officer stated, “I am extremely pleased with the results that our team delivered during 2016 and the fourth quarter, ahead of consensus estimates on EBITDA and earnings per share. Having completed our Homecare Homebase software implementation and rounding out our management team, we are already delivering a portion of the efficiencies that we promised to our stakeholders in early 2016. While the last few years have introduced quite a bit of change to the organization, our team has performed well across the board. Entering 2017, our primary goal for improvement is to return to consistent mid-single digit organic growth in home health. As a result of our efforts in the last few years, we have a solid and stable platform to build on, including a strong balance sheet that allows us to be opportunistic as we look to consolidate a fragmented industry.”
